16:14 EDT PDS Biotechnology (PDSB) files $200M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDSB:
- PDS Biotechnology Reports Promising Phase 2 Trial Results
- PDS Biotechnology Announces Promising Phase 2 Trial Results
- PDS Biotechnology announces data from its VERSATILE-002 Phase 2 trial
- PDS Biotechnology Reports Q2 2025 Financial Results
- PDS Biotechnology’s Promising Pipeline and Strong Financial Position Justify Buy Rating